Works matching IS 19450877 AND DT 2016 AND VI 9 AND IP 421

Results: 4
    1
    2

    JAK2 inhibition sensitizes resistant EGFR-mutant lung adenocarcinoma to tyrosine kinase inhibitors.

    Published in:
    Science Signaling, 2016, v. 9, n. 421, p. 1, doi. 10.1126/scisignal.aac8460
    By:
    • Gao, Sizhi P.;
    • Qing Chang;
    • Ninghui Mao;
    • Daly, Laura A.;
    • Vogel, Robert;
    • Chan, Tyler;
    • Shu Hui Liu;
    • Bournazou, Eirini;
    • Schori, Erez;
    • Haiying Zhang;
    • Brewer, Monica Red;
    • Pao, William;
    • Morris, Luc;
    • Ladanyi, Marc;
    • Arcila, Maria;
    • Manova-Todorova, Katia;
    • de Stanchina, Elisa;
    • Norton, Larry;
    • Levine, Ross L.;
    • Altan-Bonnet, Gregoire
    Publication type:
    Article
    3

    Inhibition of the kinase WNK1/HSN2 ameliorates neuropathic pain by restoring GABA inhibition.

    Published in:
    Science Signaling, 2016, v. 9, n. 421, p. 1, doi. 10.1126/scisignal.aad0163
    By:
    • Kahle, Kristopher T.;
    • Schmouth, Jean-François;
    • Lavastre, Valérie;
    • Latremoliere, Alban;
    • Jinwei Zhang;
    • Andrews, Nick;
    • Takao Omura;
    • Laganière, Janet;
    • Rochefort, Daniel;
    • Hince, Pascale;
    • Castonguay, Geneviève;
    • Gaudet, Rébecca;
    • Mapplebeck, Josiane C. S.;
    • Sotocinal, Susana G.;
    • JingJing Duan;
    • Ward, Catherine;
    • Khanna, Arjun R.;
    • Mogil, Jeffrey S.;
    • Dion, Patrick A.;
    • Woolf, Clifford J.
    Publication type:
    Article
    4